Living Well with ALK+ Lung Cancer
Finding the Balance with Treatment & Side Effects
May 19 at
4:00 PM PT / 7:00 PM ET
7:00 PM PT / 10:00 PM ET
Living with ALK+ lung cancer means constantly weighing what your treatment can do against what it does to your body. Side effects are real, dose adjustments feel scary, and it’s hard to know when to speak up.
We meet with a leading oncologist on ALK lung cancer, D. Ross Camidge, MD, PhD from Univ. of Colorado, who’s also a Stage 4 lung cancer patient himself. Along with Dr. Camidge, we are joined by Nancee Pronsati, a stage 4 ALK+ NSCLC patient advocate with ALKPositive diagnosed in 2016 who’s helped author a research paper on this exact topic. Between them, you get the clinical expertise and the lived reality in one conversation.
You will learn:
- Why ALK+ cancer spreads to the brain and which treatments are designed to stop it
- How oncologists choose between today’s first-line options and what to do when one stops working
- Which side effects to watch for on each TKI and when to call your care team
- Why a dose reduction is a strategy, not a treatment failure
- What questions to ask your oncologist about brain protection and clinical trials
- How care partners can help catch early warning signs
Program Panel
Program Sponsor
Thank you to our sponsor for their support of our independent patient education program. The Patient Story retains full editorial control over all content.
